MARKET VECTORS ETF TR - PHARMACEUTICAL (PPH)

CUSIP: 57060U217

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class
Equity / PHARMACEUTICAL
Total 13F shares
2,489,905
Share change
-257,261
Total reported value
$156,802,298
Price per share
$62.97
Number of holders
58
Value change
-$18,137,783
Number of buys
23
Number of sells
31

Quarterly Holders Quick Answers

What is CUSIP 57060U217?
CUSIP 57060U217 identifies PPH - MARKET VECTORS ETF TR - PHARMACEUTICAL in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MARKET VECTORS ETF TR - PHARMACEUTICAL (PPH) as of Q3 2015

As of 30 Sep 2015, MARKET VECTORS ETF TR - PHARMACEUTICAL (PPH) was held by 58 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,489,905 shares. The largest 10 holders included GOLDMAN SACHS GROUP INC, MORGAN STANLEY, Clal Insurance Enterprises Holdings Ltd, CREDIT SUISSE AG/, RAYMOND JAMES & ASSOCIATES, MACROVIEW INVESTMENT MANAGEMENT LLC, HOKANSON ASSOCIATES, INC., CITIGROUP INC, BANK OF AMERICA CORP /DE/, and JANE STREET GROUP, LLC. This page lists 58 institutional shareholders reporting positions in this security for the Q3 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.